Lilly to Present Retatrutide, Taltz and Zepbound Data at ACR Meeting
Lilly says it will showcase data on the drugs at ACR Convergence 2026. The supplied body begins to describe Phase 3 TRIUMPH-1 and TRIUMPH-4 results but is truncated.
Lilly says it will showcase data on the drugs at ACR Convergence 2026. The supplied body begins to describe Phase 3 TRIUMPH-1 and TRIUMPH-4 results but is truncated.